1-3 of 3
Haijun ZHang, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Novel Bio-Markers Latent Membrane Protein 1 and microRNA-155 for the Prognostic Prediction of Diffuse Large B Cell Lymphoma

Xue Wu, MD, Fei Wang, MDPhD, Yuan Li, MD, Haijun ZHang, MDPhD, Ping Liu, MD, Xiyong Wang, MD, Zheng Ge, MD PhD, Chong Gao, MD, Bao-An Chen, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 5571.
https://doi.org/10.1182/blood.V130.Suppl_1.5571.5571
Published: 2017
Journal Articles

Co-Loaded Reversal Agent and Chemotherapeutic Nanoerythrosomes to Overcome Cancer Multidrug Resistance

Shuang Ding, MSc, Baoan Chen, MDPhD, Haijun ZHang, MDPhD, Jie Yang
Journal: Blood
Blood (2017) 130 (Supplement 1): 4995.
https://doi.org/10.1182/blood.V130.Suppl_1.4995.4995
Published: 2017
Journal Articles

Wogonin As a Targeted Therapeutic Agent for EBV (+) Lymphoma Cells Involved in LMP1/NF-κB/Mir-155/PU.1 Pathway

Xue Wu, MD, Ping Liu, MD, Haijun ZHang, MDPhD, Yuan Li, MD, Jumah Masoud Mohammad Salmani, MDPhD, Fei Wang, MDPhD, Ke Yang, MD, Rong Fu, PhD, Baoan Chen, MDPhD, Zhewei Chen
Journal: Blood
Blood (2017) 130 (Supplement 1): 5204.
https://doi.org/10.1182/blood.V130.Suppl_1.5204.5204
Published: 2017